VALN
Price:
$5.355
Market Cap:
$433.53M
Valneva SE operates as a specialized biopharmaceutical company, concentrating its efforts on developing and bringing to market preventative vaccines for infectious diseases where current medical options are insufficient. Its portfolio of commercial travel vaccines includes IXIARO, an inactivated vaccine derived from Vero cell culture, which provides active immunity against Japanese encephalitis. Another offering is DUKORAL, an oral vaccine designed to guard against diarrhea induced by Vibrio cholerae or enterotoxigenic Escherichia coli (ETEC) bacteria. The company's development pipeline features VLA2001, a candidate vaccine targeting SARS-CoV-2. Additionally, Valneva is progressing with VLA1...[Read more]
Industry
Biotechnology
IPO Date
2021-05-05
Stock Exchange
NASDAQ
Ticker
VALN
According to Valneva SE’s latest financial reports and current stock price. The company's current PE Ratio is -2.89. This represents a change of -41.54% compared to the average of -4.94 of the last 4 quarters.
The mean historical PE Ratio of Valneva SE over the last ten years is -16.69. The current -2.89 PE Ratio has changed 1.63% with respect to the historical average. Over the past ten years (40 quarters), VALN's PE Ratio was at its highest in in the December 2019 quarter at 85.65. The PE Ratio was at its lowest in in the September 2019 quarter at -2020.93.
Average
-16.69
Median
-8.69
Minimum
-135.20
Maximum
78.21
Discovering the peaks and valleys of Valneva SE PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 306.50%
Maximum Annual PE Ratio = 78.21
Minimum Annual Increase = -510.19%
Minimum Annual PE Ratio = -135.20
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -5.43 | -78.87% |
| 2024 | -25.70 | 297.45% |
| 2023 | -6.47 | 28.90% |
| 2022 | -5.02 | -84.60% |
| 2021 | -32.57 | 198.20% |
| 2020 | -10.92 | -91.92% |
| 2019 | -135.20 | -272.86% |
| 2018 | 78.21 | -510.19% |
| 2017 | -19.07 | 306.50% |
| 2016 | -4.69 | -65.74% |
The current PE Ratio of Valneva SE (VALN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-12.53
5-year avg
-15.04
10-year avg
-16.69
Valneva SE’s PE Ratio is greater than Day One Biopharmaceuticals, Inc. (-20.74), less than Arvinas, Inc. (-2.19), greater than ArriVent BioPharma, Inc. Common Stock (-9.48), greater than Astria Therapeutics, Inc. (-5.88), greater than Geron Corporation (-11.06), less than Replimune Group, Inc. (-2.60), greater than MeiraGTx Holdings plc (-6.47), greater than MBX Biosciences, Inc. Common Stock (-19.10), less than Ginkgo Bioworks Holdings, Inc. (-1.54), greater than Iovance Biotherapeutics, Inc. (-4.83),
| Company | PE Ratio | Market cap |
|---|---|---|
| -20.74 | $2.22B | |
| -2.19 | $489.07M | |
| -9.48 | $1.42B | |
| -5.88 | $718.13M | |
| -11.06 | $737.75M | |
| -2.60 | $733.24M | |
| -6.47 | $888.13M | |
| -19.10 | $1.19B | |
| -1.54 | $515.41M | |
| -4.83 | $1.46B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Valneva SE using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Valneva SE or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Valneva SE's PE Ratio?
How is the PE Ratio calculated for Valneva SE (VALN)?
What is the highest PE Ratio for Valneva SE (VALN)?
What is the 3-year average PE Ratio for Valneva SE (VALN)?
What is the 5-year average PE Ratio for Valneva SE (VALN)?
How does the current PE Ratio for Valneva SE (VALN) compare to its historical average?